This is an outdated version published on 2022-12-21. Read the most recent version.

Intratympanic Steroid Therapy For Treatment Of Idiopathic Sudden Sensorineural Hearing Loss As Salvage Therapy.

Authors

  • Dr. Apurab Gupta , Dr. Bonita Gupte , Dr. Parmod Kalsotra , Dr. Gopika Kalsotra

DOI:

https://doi.org/10.47750/pnr.2022.13.S01.285

Abstract

Idiopathic sudden sensorineural hearing loss (ISSHL) is the sudden loss of unilateral hearing of unknown etiology. The standard
treatment consists of a high dose oral steroid taper. This article serves to review the current study on the use of Intratympanic steroid
injections for ISSHL. Purpose- of the study to know the efficacy of Intratympanic steroid therapy in patients with idiopathic sensorineural hearing loss (ISSHL) who had not responded to intravenous treatment. Materials and Methods-Our study consists of 110 patients with refractory ISSHL.
Results- overall 60 patients showed improvement in PTA. Conclusions-IST is an effective and safe therapy in sudden sensorineural
hearing loss cases that are refractory to standard treatment.

Downloads

Published

2022-12-21

Versions

Issue

Vol. 13 SPECIAL ISSUE 01 (2022)

Section

Articles

How to Cite

Intratympanic Steroid Therapy For Treatment Of Idiopathic Sudden Sensorineural Hearing Loss As Salvage Therapy. (2022). Journal of Pharmaceutical Negative Results, 2399-2401. https://pnrjournal.com/index.php/home/article/view/5192